Special Issue "Regenerative Ophthalmology: From Molecular Basis to Therapy"
Deadline for manuscript submissions: 30 September 2022 | Viewed by 1688
Interests: stem cells
Interests: translational medical research; novel targets in dermatology, ophthalmology, oral and maxillofacial surgery; bone substitutes; cancer; head and neck cancer; surgery
The eye is a complex system composed of various structures and tissues. The synergy between them guarantees proper sight. Because of the different structures, their defects can have several origins, all leading to an impaired vision.
During the last decade, research on ophthalmology has been taking huge leaps forward by uncovering new avenues for clinical applications. With the recent advancements in genomic and molecular medicine, the pathologies hindering sight have never been so thoroughly described, helping clinicians to diagnose and treat patients earlier and faster than ever before. In the scope of this issue, we are presenting an overview of the advancements in the field.
The development of new technologies, such as single-cell resolution -omics, or gene therapy, together with a deeper understanding over the genome and how its organization impacts cellular pathophysiology, provide scientists with a perfect momentum to unravel biological mechanisms underlying pathologies and swiftly propose new clinical avenues to treat affected patients.
This Special Issue of Biomedicines aims at highlighting these new findings, their impacts on disease management, and novel treatment discoveries which aim to retain or even regain sight. In this context, this Special Issue also deciphers the future of the general direction of visual science and tomorrow’s challenges but also possibilities in ocular medicine.
Dr. Frederic Michon
Dr. Paolo Boffano
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- optic nerve
- tear film
- single-cell -omics
- gene therapy